Premium
The furosemide diagnostic test in suspected slow‐onset heart failure: popular but not useful
Author(s) -
Kelder Johannes C.,
Cramer Maarten J.,
Rutten Frans H.,
Plokker H.W.,
Grobbee Diederick E.,
Hoes Arno W.
Publication year - 2011
Publication title -
european journal of heart failure
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 5.149
H-Index - 133
eISSN - 1879-0844
pISSN - 1388-9842
DOI - 10.1093/eurjhf/hfr010
Subject(s) - furosemide , medicine , heart failure , loop diuretic , diuretic , test (biology) , diagnostic test , intensive care medicine , cardiology , pediatrics , paleontology , biology
Aims Early, slow‐onset heart failure is difficult to diagnose from just signs and symptoms. The physician needs ancillary diagnostic tests. The ‘loop‐diuretic test’ or ‘furosemide test’, characterized as weight loss and alleviation of symptoms after a short course of a loop‐diuretic, could be a candidate. The furosemide test is not formally mentioned in the guidelines and no evidence could be found in the literature. We asked general practitioners (GPs) about their actual use of the furosemide test and studied the diagnostic accuracy in patients with suspected heart failure. Methods and results General practitioners completed a questionnaire about their use of the furosemide test. We then performed a diagnostic accuracy study among a representative and consecutive sample of patients suspected of new, slow‐onset heart failure by the GP and who were referred to the rapid access heart failure diagnostic facility of one hospital. All patients underwent a standardized diagnostic work‐up including echocardiography. The reference standard for the diagnosis of heart failure was the decision of an expert panel. Forty of the 54 GPs had actually used the furosemide test in the past year and 70% considered the test to be useful. Forty seven patients underwent the furosemide test and 12 (25%) were diagnosed with heart failure. None of the effects of the test (weight loss, alleviation of symptoms) was significantly associated with heart failure. Conclusion We cannot support the use of the furosemide test as an ancillary diagnostic test in patients suspected of new, slow‐onset heart failure.